Trial Profile
Study of Antiinflammatory Effects of Detralex (Daflon) in Patients With Chronic Venous Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs S 5682 (Primary)
- Indications Venous insufficiency
- Focus Pharmacodynamics
- 31 Oct 2019 Status changed from recruiting to completed.
- 24 May 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2019.
- 24 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 May 2019.